Today: 7 February 2026
Subscribe
Browse Category

Stock Market News 3 December 2025

UiPath (PATH) Surges After Q3 Fiscal 2026 Earnings and Guidance Top Wall Street Expectations

UiPath (PATH) Surges After Q3 Fiscal 2026 Earnings and Guidance Top Wall Street Expectations

NEW YORK — December 3, 2025 UiPath Inc. (NYSE: PATH) delivered a stronger-than-expected fiscal third quarter 2026 on Wednesday, posting double‑digit revenue growth, higher‑than‑forecast non‑GAAP earnings, and an upbeat outlook that sent the automation specialist’s shares sharply higher in regular and after‑hours trading. UiPath, Inc.+1 The results mark a key milestone for the company: UiPath reported its first GAAP‑profitable third quarter while continuing to invest heavily in AI‑driven “agentic automation” and an expanding partner ecosystem. UiPath, Inc.+1 Earnings Beat: Revenue, ARR and Profitability All Move Higher For the quarter ended October 31, 2025, UiPath reported: UiPath, Inc.+1 On the bottom line, UiPath reported: UiPath,
3 December 2025
····
Stellantis Stock (STLA) Soars on UBS Upgrade and U.S. Jobs Push: News, Forecasts and Risks on December 3, 2025

Stellantis Stock (STLA) Soars on UBS Upgrade and U.S. Jobs Push: News, Forecasts and Risks on December 3, 2025

Stellantis stock is back on traders’ screens today. On December 3, 2025, shares of Stellantis N.V. (NYSE: STLA) are rallying after a powerful combination of catalysts: a UBS upgrade to “Buy”, fresh details on a major U.S. hiring and investment drive, and a steady stream of regulatory and legal headlines that will shape the automaker’s future. As of the U.S. close, STLA is trading around $11.5 per share, up roughly 4–5% on the day, with a 52‑week range of about $8.39–$14.28. On the Milan exchange, Stellantis is among the top gainers, with the stock jumping around 7–8% to just under
3 December 2025
····
Mastercard Stock (MA) Today: AI Payments, Analyst Price Targets and 2026 Outlook – December 3, 2025

Mastercard Stock (MA) Today: AI Payments, Analyst Price Targets and 2026 Outlook – December 3, 2025

Published: December 3, 2025 – Information only, not investment advice. Mastercard stock on 3 December 2025: price and market snapshot As of the close on December 3, 2025, Mastercard Incorporated (NYSE: MA) is trading around $553.73 per share, modestly higher on the day and roughly mid‑range in its 52‑week band. Recent filings and price data show: Mastercard also pays a quarterly dividend of $0.76 per share (annualized $3.04, yield close to 0.6%) with a payout ratio under 20%, leaving plenty of room to reinvest in growth while still returning cash to shareholders. MarketBeat Institutional ownership remains extremely high at roughly
3 December 2025
····
Goldman Sachs (GS) Stock on December 3, 2025: Near Record Highs After Dividend Hike, $2 Billion ETF Deal and Mixed 2026 Forecasts

Goldman Sachs (GS) Stock on December 3, 2025: Near Record Highs After Dividend Hike, $2 Billion ETF Deal and Mixed 2026 Forecasts

Data and prices in this article are as of the U.S. close on December 3, 2025. 1. Goldman Sachs stock today: price, valuation and performance The Goldman Sachs Group, Inc. (NYSE: GS) ended trading on December 3, 2025 around $836–837 per share, near its 52‑week high of $841.28. That gives the Wall Street bank a market capitalization of roughly $260 billion, with a trailing P/E near 17x, forward P/E in the mid‑teens, and dividend yield just under 2%. StockAnalysis+1 Over the past year, Goldman Sachs stock has climbed about 36–40%, far outpacing the broader financial sector and the S&P 500.
3 December 2025
····
Amgen (AMGN) Stock Hits New 52‑Week High as Obesity Drug Bets and Analyst Upgrades Fuel 2025 Rally

Amgen (AMGN) Stock Hits New 52‑Week High as Obesity Drug Bets and Analyst Upgrades Fuel 2025 Rally

Published: December 3, 2025 Amgen Inc. (NASDAQ: AMGN) is closing out 2025 on a powerful upswing. As of the close on December 3, 2025, Amgen shares finished at $345.42, up about 2% on the day, and nudged higher in after-hours trading.StockAnalysis The move pushed the biotech giant to a fresh 52‑week high near $345.95, extending a year-to-date rally of roughly 35%–37% and a one‑year gain of more than 25%.Investing.com+1 Behind the rally is a cluster of catalysts: strong third‑quarter earnings, a deepening obesity drug story around MariTide, aggressive Phase 3 programs, analyst price‑target hikes, and rising institutional ownership. At the
3 December 2025
····
Freeport-McMoRan (FCX) Stock Soars as Copper Rallies but Lawsuits Mount: Latest News and 2026–2027 Outlook (December 3, 2025)

Freeport-McMoRan (FCX) Stock Soars as Copper Rallies but Lawsuits Mount: Latest News and 2026–2027 Outlook (December 3, 2025)

This article is for informational purposes only and does not constitute financial or legal advice. FCX Stock Today: Strong Rebound but Still Below Its Highs On Wednesday, December 3, 2025, Freeport-McMoRan Inc. (NYSE: FCX) closed at $44.53, up 3.63% on the day and comfortably ahead of the broader market, which also posted modest gains. Trading volume hit about 22.8 million shares, above the recent 50‑day average of 20.5 million, underscoring renewed investor interest. Despite the rally, FCX still trades roughly 9.3% below its 52‑week high of $49.12 set on July 8. MarketWatch Fundamentally, FCX remains a large-cap, copper‑levered play: recent
3 December 2025
·····
D-Wave Quantum (QBTS) Stock on December 3, 2025: New U.S. Government Unit, Evercore’s $44 Target and What It Means for Investors

D-Wave Quantum (QBTS) Stock on December 3, 2025: New U.S. Government Unit, Evercore’s $44 Target and What It Means for Investors

As of December 3, 2025, D-Wave Quantum Inc. (NYSE: QBTS) is again at the center of the quantum-computing story on Wall Street. A new U.S. government-focused business unit, a fresh “Outperform” initiation from Evercore ISI with a $44 price target, and a flurry of valuation debates have turned the stock into one of the most closely watched high‑risk tech names on the market. TS2 Tech+2Quantum Zeitgeist+2 Below is a detailed, SEO-friendly rundown of today’s news, analyst forecasts, fundamentals, bull vs. bear arguments, and what could move QBTS next. This article is informational only and not investment advice. Quick Snapshot: QBTS
3 December 2025
····
Eaton Corporation (ETN) Stock Outlook Today: AI Data Centers, Boyd Thermal Deal and 2026 Growth Prospects (3 December 2025)

Eaton Corporation (ETN) Stock Outlook Today: AI Data Centers, Boyd Thermal Deal and 2026 Growth Prospects (3 December 2025)

Eaton Corporation plc (NYSE: ETN) has become one of the most closely watched industrial names in the AI infrastructure boom. As of December 3, 2025, the stock is trading in the mid‑$330s, roughly 17% below its late‑July 52‑week high near $400 after a sharp pullback following earnings and a wave of macro jitters.MarketWatch+1 Yet behind the recent volatility sits a company reporting record results, leaning hard into AI‑driven data centers and grid modernization, and preparing for a major $9.5 billion acquisition that could reshape its role in the cooling side of the data‑center stack.Eaton+1 Below is a deep dive into
3 December 2025
·····
Pfizer Stock (PFE) Today – Price, Metsera Obesity Bet, RSV Vaccine Tailwinds and 2026 Forecast (3 December 2025)

Pfizer Stock (PFE) Today – Price, Metsera Obesity Bet, RSV Vaccine Tailwinds and 2026 Forecast (3 December 2025)

Pfizer Inc. (NYSE: PFE) remains one of the most closely watched healthcare stocks as of December 3, 2025. The share price is still stuck near post‑COVID lows, but a new $10 billion obesity‑drug acquisition, expanding RSV vaccine markets and a hefty dividend yield around 6.5–7% are reshaping the narrative around the stock. Pfizer+2Pfizer+2 Below is a deep dive into where Pfizer stock stands today, which headlines are moving it, and how Wall Street currently values PFE for 2026 and beyond. 1. Pfizer stock today: price, trading range and valuation As of late trading on December 3, 2025, Pfizer shares are
3 December 2025
···
Singapore Stock Market Outlook: 10 Things to Know Before the STI Opens on Thursday, 4 December 2025

Singapore Stock Market Outlook: 10 Things to Know Before the STI Opens on Thursday, 4 December 2025

As Singapore investors wake up for Thursday’s session on 4 December 2025, the Straits Times Index (STI) is coming off a six‑day winning streak, Wall Street has closed higher again, and a rare blockbuster tech‑healthcare IPO has just lit up the SGX board. Here’s a comprehensive look at what’s driving sentiment and which themes may matter when the opening bell rings. 1. STI closes at six‑day high ahead of Thursday’s open Singapore’s benchmark STI finished Wednesday, 3 December, up 16.56 points, or almost 0.4%, at 4,554.52, marking its sixth consecutive gain. The iEdge Singapore Next 50 Index also rose by
3 December 2025
·····
New Zealand Stock Market Outlook for 4 December 2025: 10 Things to Know Before the NZX Opens

New Zealand Stock Market Outlook for 4 December 2025: 10 Things to Know Before the NZX Opens

The New Zealand sharemarket heads into Thursday’s open on the back of a two‑day rally, a fresh Fonterra update, and growing optimism that global central banks are done with aggressive tightening. Here’s a detailed look at what’s likely to shape trading on Thursday, 4 December 2025. Quick snapshot before the bell Below, we unpack the moving parts. 1. How the NZX closed on Wednesday Wednesday’s session on 3 December 2025 set a constructive tone: Key movers: In short, the market is entering Thursday with positive momentum, powered by heavyweights and yield names rather than speculative microcaps. 2. Overnight global leads:
3 December 2025
·········
Synopsys (SNPS) Stock on December 3, 2025: Nvidia’s $2 Billion Bet, Class‑Action Lawsuits and New Analyst Forecasts

Synopsys (SNPS) Stock on December 3, 2025: Nvidia’s $2 Billion Bet, Class‑Action Lawsuits and New Analyst Forecasts

Synopsys, Inc. (NASDAQ: SNPS) is back in the market spotlight after a volatile few months. On Wednesday, December 3, 2025, the stock extended a sharp rebound driven by Nvidia’s $2 billion strategic investment, even as fresh class‑action lawsuits and mixed analyst messages kept risks firmly on the radar. As of the U.S. close on December 3, Synopsys shares were trading around the mid‑$460s, up roughly 4% on the day and about 20% above their early‑November lows, but still well below the 52‑week high near $652 reached before the September earnings shock.StockAnalysis+1 Below is a detailed look at what changed on
3 December 2025
···
1 … 1,487 1,488 1,489 1,490 1,491 … 1,915

Stock Market Today

South32 share price drops 4% in ASX rout — what investors watch before results

South32 share price drops 4% in ASX rout — what investors watch before results

7 February 2026
Sydney, Feb 7, 2026, 17:39 AEDT — Market closed. South32 Ltd shares (S32.AX) closed down 4.1% at A$4.41 on Friday, hit by the same risk-off wave that pushed Australian miners sharply lower. The stock traded between A$4.37 and A$4.51 and was down 19 cents from the prior close of A$4.60. (Intelligent Investor) With markets shut for the weekend, the move leaves South32 on the watchlist going into Monday’s open as investors reassess exposure to metals and mining names. The S&P/ASX 200 ended the week down 1.81%. (Morningstar) The benchmark fell 2% on Friday and almost A$70 billion was wiped off
Wesfarmers share price: what to watch on ASX next week as results loom

Wesfarmers share price: what to watch on ASX next week as results loom

7 February 2026
Wesfarmers shares closed down 1.33% at A$85.04 on Friday, following a sharp drop in the S&P/ASX 200, which fell 2% for its steepest one-day loss in 10 months. Investors are watching for Australia’s household spending data next week and Wesfarmers’ half-year results due Feb. 19.
Go toTop